$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 29/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 29/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 179.13 | 10,000 | 1,791,300 | 13,500 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 52.03 | 2,224 | 115,715 | 0 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 658.00 | 11 | 7,238 | 17,501 | 17.5 K to 17.5 K (-0.06 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 647.79 | 82 | 53,119 | 17,512 | 17.6 K to 17.5 K (-0.47 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 646.82 | 155 | 100,257 | 17,594 | 17.7 K to 17.6 K (-0.87 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 645.33 | 72 | 46,464 | 17,749 | 17.8 K to 17.7 K (-0.40 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 644.57 | 303 | 195,305 | 17,821 | 18.1 K to 17.8 K (-1.67 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 643.49 | 691 | 444,652 | 18,124 | 18.8 K to 18.1 K (-3.67 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 642.39 | 676 | 434,256 | 18,815 | 19.5 K to 18.8 K (-3.47 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 641.58 | 855 | 548,551 | 19,491 | 20.3 K to 19.5 K (-4.20 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 640.61 | 113 | 72,389 | 20,346 | 20.5 K to 20.3 K (-0.55 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 639.64 | 75 | 47,973 | 20,459 | 20.5 K to 20.5 K (-0.37 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 638.51 | 306 | 195,384 | 20,534 | 20.8 K to 20.5 K (-1.47 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 637.88 | 154 | 98,234 | 20,840 | 21 K to 20.8 K (-0.73 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 636.56 | 216 | 137,497 | 20,994 | 21.2 K to 21 K (-1.02 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 52.03 | 2,224 | 115,715 | 21,210 | 19 K to 21.2 K (+11.71 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Payment of Exercise | F | 655.57 | 6,291 | 4,124,191 | 18,986 | 25.3 K to 19 K (-24.89 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 179.13 | 10,000 | 1,791,300 | 25,277 | 15.3 K to 25.3 K (+65.46 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 555.67 | 5,000 | 2,778,350 | 5,000 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 3,500 | 1,398,810 | 25,000 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 658.00 | 3 | 1,974 | 24,669 | 24.7 K to 24.7 K (-0.01 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 647.50 | 388 | 251,230 | 24,672 | 25.1 K to 24.7 K (-1.55 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 655.57 | 4,611 | 3,022,833 | 25,060 | 29.7 K to 25.1 K (-15.54 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 555.67 | 5,000 | 2,778,350 | 29,671 | 24.7 K to 29.7 K (+20.27 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 655.57 | 2,802 | 1,836,907 | 24,671 | 27.5 K to 24.7 K (-10.20 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 3,500 | 1,398,810 | 27,473 | 24 K to 27.5 K (+14.60 %) |